News
-
-
-
PRESS RELEASE
AB Science - New peer-reviewed data provide strong evidence supporting masitinib potential for the treatment of Alzheimer’s disease
New peer-reviewed data supports masitinib's potential for treating Alzheimer's disease through cognitive enhancement and neuroprotection. Phase 3 study authorized by FDA and key EU countries -
-
-
PRESS RELEASE
YOC AG REPORTS ACCELERATED REVENUE GROWTH IN Q2 2025 BASED ON PRELIMINARY FIGURES
YOC AG reports accelerated revenue growth in Q2 2025 based on preliminary figures. Revenue up 10% YoY in H1 2025, with Q2 expected to grow 15-18%. Advances in programmatic trading and AI solutions drive growth -
-
-
-